SYNOPSYS INC — Director's Dealing 2023

Feb 22, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: SYNOPSYS INC (SNPS)
CIK: 0000883241
Period of Report: 2023-02-17

Reporting Person: RUNKEL JOHN F JR (GC & Corporate Secretary)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-12-13	Common Stock	G	650	$0.0	Disposed	25212	Direct
2022-12-14	Common Stock	G	100	$0.0	Disposed	25112	Direct
2023-02-17	Common Stock	M	569	$234.17	Acquired	25681	Direct
2023-02-17	Common Stock	S	569	$353.9073	Disposed	25112	Direct
2023-02-17	Common Stock	M	1572	$135.88	Acquired	26684	Direct
2023-02-17	Common Stock	S	1572	$353.9073	Disposed	25112	Direct
2023-02-17	Common Stock	M	1323	$89.76	Acquired	26435	Direct
2023-02-17	Common Stock	S	1323	$353.9073	Disposed	25112	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2023-02-17	Non-Qualified Stock Option (right to buy)	$89.76	M	1323	Disposed	2025-12-12	Common Stock (1323)	Direct
2023-02-17	Non-Qualified Stock Option (right to buy)	$135.88	M	1572	Disposed	2026-12-12	Common Stock (1572)	Direct
2023-02-17	Non-Qualified Stock Option (right to buy)	$234.17	M	569	Disposed	2027-12-10	Common Stock (569)	Direct
2023-02-17	Non-Qualified Stock Option (right to buy)	$354.45	A	4875	Acquired	2030-02-17	Common Stock (4875)	Direct
2023-02-17	Restricted Stock Units	$0.0	A	1623	Acquired	2027-03-15	Common Stock (1623)	Direct

Footnotes

F1: Gift

F2: Represents a weighted average sale price per share. These shares were sold in multiple transactions at prices ranging from $350.83 to $357.39. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares purchased at each separate price within the range.

F3: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.

F4: 1/4 of the grant becomes exercisable on the date shown with the remainder becoming exercisable in a series of 12 equal quarterly installments thereafter, subject to continued service through each vesting date.

F5: Grant to reporting person to buy shares of common stock under the Synopsys, Inc 2006 Employee Equity Incentive Plan.

F6: The Compensation Committee of the Board of Directors approved a restricted stock unit grant under the Synopsys, Inc. 2006 Employee Equity Incentive Plan.

F7: 25% of the units vest on the date shown followed by three equal annual installments, subject to continued service through each vesting date.